Manning, M.

Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics

Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 423

Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆

MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 296

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor

Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp‐Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., & Jard, S. (1995) · The EMBO Journal

Receptor Mechanisms and SignalingNeuroendocrine regulation and behavior

Cited by 179

Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges

Chini, B., & Manning, M. (2007) · Biochemical Society Transactions

Receptor Mechanisms and SignalingNeuroendocrine regulation and behavior

Cited by 123

[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors

Derick, S., Cheng, L. L., Voirol, M. J., Stoev, S., Giacomini, M., Wo, N. C., Szeto, H. H., Ben Mimoun, M., Andres, M., Gaillard, R. C., et al. (2002) · Endocrinology

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 76

Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an “easy guide” to receptor pharmacology

CHINI, B., MANNING, M., & GUILLON, G. (2008) · Progress in Brain Research

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 65